このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Early Nutrition and Heart Structure and Function in Preterm Infants During the First Year of Life

2026年11月4日 更新者:Ahmed Elhady Ragaey Mahmoud、Assiut University

Study the Association of Early Nutritional Exposure With Cardiac Structure and Function in Preterm Infants During the First Year of Life: A Prospective Study

Preterm infants are babies born before 37 completed weeks of pregnancy. Early nutrition is important for their growth and development, and it may also be associated with how their heart develops and functions during infancy.

This prospective observational study aims to investigate the association between early nutritional exposure during the neonatal period and cardiac structure and function at 12 months of corrected age in preterm infants. The study will be conducted at Assiut University Hospital and El-Eman General Hospital in Assiut, Egypt.

Preterm infants born before 37 weeks of gestation who are admitted to the neonatal unit within 24 hours of birth, have adequate records of their nutritional intake, and whose parents provide written informed consent will be considered for participation. Infants with major congenital heart disease, known congenital cardiomyopathy, major genetic or chromosomal abnormalities, or other specified exclusion criteria will not be included.

The study will collect information about maternal and neonatal characteristics, neonatal complications, feeding patterns, growth, and anthropometric measurements. Cardiac structure and function will be assessed using echocardiography at birth, 6 months, and approximately 12 months of corrected age. Growth measurements will also be recorded at different time points, including 12 months of corrected age.

The study will compare cardiac measurements and growth outcomes among infants with different early nutritional exposures. It will also investigate which early nutritional and clinical factors are associated with left ventricular mass index at 12 months of corrected age.

The findings may improve understanding of the relationship between early nutrition and cardiovascular development in preterm infants. Participation will involve clinical data collection, growth measurements, and echocardiographic assessments, with written informed consent obtained from parents or legal guardians.

調査の概要

状態

まだ募集していません

条件

介入・治療

詳細な説明

This prospective observational study will investigate the association between early nutritional exposure during the neonatal period and cardiac structure and function during the first year of life in preterm infants.

**Study Setting and Population**

The study will be conducted at the Department of Pediatric Medicine, Assiut University Hospital and El-Eman General Hospital, Assiut, Egypt. The study population will include preterm infants born before 37 completed weeks of gestation who are admitted to the neonatal unit within 24 hours of birth, have adequate nutritional records, and whose parents provide written informed consent. Infants must be available for follow-up echocardiographic assessment at 12 months of corrected age.

**Eligibility Criteria**

Infants with major congenital heart disease, known congenital cardiomyopathy, major chromosomal or genetic abnormalities, congenital anomalies, or infections associated with or potentially affecting cardiac disease will be excluded. Infants with inadequate nutritional records, those whose parents refuse written consent, and those without follow-up at one year will also be excluded.

**Nutritional Exposure Groups**

The protocol describes the following feeding groups:

  1. Preterm infants receiving early complementary feeding at 17 weeks.
  2. Preterm infants receiving late complementary feeding after 26 weeks.
  3. Preterm infants receiving breastfeeding.
  4. Preterm infants receiving artificial feeding.
  5. Preterm infants receiving both breast milk and artificial feeding.

Nutritional exposure will be evaluated in relation to cardiac and growth outcomes. The final operational definitions and classification of feeding groups will follow the study protocol.

**Data Collection**

Maternal information will include maternal age, parity, mode of conception, obstetric history and complications, antenatal corticosteroid and magnesium sulfate administration, and mode of delivery.

Neonatal information will include sex, gestational age, singleton or multiple birth, birth weight, length, head circumference, small-for-gestational-age, appropriate-for-gestational-age or large-for-gestational-age classification, Apgar scores, and resuscitation requirements. Neonatal complications will include respiratory distress syndrome, surfactant use, duration of ventilation, and length of hospital stay.

Anthropometric measurements, including weight, length, and head circumference, will be recorded at birth, 36 weeks of postmenstrual age, hospital discharge, and 12 months of corrected age. Appropriate growth z-scores will be calculated using relevant reference standards.

**Echocardiographic Assessment**

Echocardiography will be performed at birth, 6 months, and approximately 12 months of corrected age (±2 weeks) by a single trained pediatric cardiologist blinded to the feeding group.

Cardiac structural measurements will include left ventricular end-diastolic and end-systolic dimensions, septal and posterior wall thickness, left ventricular mass index, relative wall thickness, left ventricular sphericity index, left atrial size, right ventricular basal dimension, and aortic root dimensions.

Cardiac functional measurements will include left ventricular ejection fraction and global longitudinal strain; mitral E/A ratio, septal and lateral e', E/e' ratio, and isovolumetric relaxation time; tricuspid annular plane systolic excursion, tricuspid S', right ventricular fractional area change, right ventricular free-wall strain, pulmonary acceleration time, and septal configuration. Patent foramen ovale and patent ductus arteriosus, if identified, will be documented as incidental findings.

**Study Outcomes and Statistical Analysis**

The primary objective is to investigate the association between early nutritional strategies and cardiac structure and function at 12 months of corrected age.

Secondary objectives include comparing left ventricular mass index z-scores, other echocardiographic parameters, and anthropometric outcomes among feeding groups, and developing a predictive model to identify early nutritional and clinical factors associated with left ventricular mass index at 12 months.

Data will be analyzed using the Statistical Package for the Social Sciences (SPSS). Continuous variables will be summarized as mean ± standard deviation or median and interquartile range, as appropriate. Categorical variables will be presented as frequencies and percentages. Comparisons will use one-way analysis of variance or the Kruskal-Wallis test, with appropriate post hoc correction, and the chi-square test or Fisher's exact test for categorical variables. Multivariable linear regression will be used for the predictive model. A p-value below 0.05 will be considered statistically significant.

Written informed consent will be obtained from parents or legal guardians, and participant information will be handled confidentially by the research team.

研究の種類

観察的

入学 (推定)

80

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

1年~1年 (子)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

サンプリング方法

非確率サンプル

調査対象母集団

Preterm infants at 1 year old age with past nutritional history avalible

説明

Inclusion Criteria:

  • Preterm infants born at <37 weeks of gestation.
  • preterm Infants admitted to the neonatal unit within 24 hours of birth.
  • preterm Infants who have adequate records of nutritional intake during the neonatal period.
  • Parents provided a consent for participation.
  • preterm Infants available for follow-up echocardiographic assessment at 12 months corrected age.

Exclusion Criteria:

  • preterm Infants with major congenital heart disease or known congenital cardiomyopathy.
  • preterm Infants with major chromosomal, genetic abnormalities, congenital anomaly, or infections associated with or have potential for cardiac disease.
  • Inadequate nutritional records.
  • Refusal to provide written consent.
  • Lack of follow-up at one year.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 観測モデル:COHORT
  • 時間の展望:PROSPECTIVE

コホートと介入

グループ/コホート
介入・治療
- Group 1: Includes preterm Infants how receive early complementary feeding at 17 weeks.

Echocardiography is performed at Birth , 6 months and after 12 months corrected age

Echocardiography is performed at Birth , 6 months and after 12 months corrected age (±2 weeks) by a single trained pediatric cardiologist blinded to the feeding group. The following parameters will be reported:

  • Cardiac structure: LV end-diastolic and end-systolic dimensions, septal and posterior wall thickness, LV mass index, relative wall thickness, LV sphericity index, left atrial size, RV basal dimension, and aortic root.
  • Cardiac function: LV ejection fraction, and global longitudinal strain; mitral E/A, septal and lateral e', E/e', and IVRT; TAPSE, tricuspid S', RV fractional area change, and RV free-wall strain; pulmonary acceleration time, and septal configuration. Note any PFO or PDA is incidental finding.
- Group 2: includes preterm infants how receive late complementary feeding After 26 weeks.

Echocardiography is performed at Birth , 6 months and after 12 months corrected age

Echocardiography is performed at Birth , 6 months and after 12 months corrected age (±2 weeks) by a single trained pediatric cardiologist blinded to the feeding group. The following parameters will be reported:

  • Cardiac structure: LV end-diastolic and end-systolic dimensions, septal and posterior wall thickness, LV mass index, relative wall thickness, LV sphericity index, left atrial size, RV basal dimension, and aortic root.
  • Cardiac function: LV ejection fraction, and global longitudinal strain; mitral E/A, septal and lateral e', E/e', and IVRT; TAPSE, tricuspid S', RV fractional area change, and RV free-wall strain; pulmonary acceleration time, and septal configuration. Note any PFO or PDA is incidental finding.
- Group 3: includes preterm infants how receive breast feeding.

Echocardiography is performed at Birth , 6 months and after 12 months corrected age

Echocardiography is performed at Birth , 6 months and after 12 months corrected age (±2 weeks) by a single trained pediatric cardiologist blinded to the feeding group. The following parameters will be reported:

  • Cardiac structure: LV end-diastolic and end-systolic dimensions, septal and posterior wall thickness, LV mass index, relative wall thickness, LV sphericity index, left atrial size, RV basal dimension, and aortic root.
  • Cardiac function: LV ejection fraction, and global longitudinal strain; mitral E/A, septal and lateral e', E/e', and IVRT; TAPSE, tricuspid S', RV fractional area change, and RV free-wall strain; pulmonary acceleration time, and septal configuration. Note any PFO or PDA is incidental finding.
-Group 4: includes preterm infants who receive artificial feeding.

Echocardiography is performed at Birth , 6 months and after 12 months corrected age

Echocardiography is performed at Birth , 6 months and after 12 months corrected age (±2 weeks) by a single trained pediatric cardiologist blinded to the feeding group. The following parameters will be reported:

  • Cardiac structure: LV end-diastolic and end-systolic dimensions, septal and posterior wall thickness, LV mass index, relative wall thickness, LV sphericity index, left atrial size, RV basal dimension, and aortic root.
  • Cardiac function: LV ejection fraction, and global longitudinal strain; mitral E/A, septal and lateral e', E/e', and IVRT; TAPSE, tricuspid S', RV fractional area change, and RV free-wall strain; pulmonary acceleration time, and septal configuration. Note any PFO or PDA is incidental finding.
- Group 5: includes preterm infants who receive both breast and artificial feeding.

Echocardiography is performed at Birth , 6 months and after 12 months corrected age

Echocardiography is performed at Birth , 6 months and after 12 months corrected age (±2 weeks) by a single trained pediatric cardiologist blinded to the feeding group. The following parameters will be reported:

  • Cardiac structure: LV end-diastolic and end-systolic dimensions, septal and posterior wall thickness, LV mass index, relative wall thickness, LV sphericity index, left atrial size, RV basal dimension, and aortic root.
  • Cardiac function: LV ejection fraction, and global longitudinal strain; mitral E/A, septal and lateral e', E/e', and IVRT; TAPSE, tricuspid S', RV fractional area change, and RV free-wall strain; pulmonary acceleration time, and septal configuration. Note any PFO or PDA is incidental finding.

この研究は何を測定していますか?

主要な結果の測定

結果測定
時間枠
to investigate the association between early nutritional strategies and cardiac structure and function at 12 months of corrected age.
時間枠:one year old age of preterm infants
one year old age of preterm infants

二次結果の測定

結果測定
時間枠
comparing left ventricular mass index z-scores, other echocardiographic parameters, and anthropometric outcomes among feeding groups
時間枠:over one year period study
over one year period study

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年12月1日

一次修了 (推定)

2027年12月1日

研究の完了 (推定)

2027年12月30日

試験登録日

最初に提出

2026年10月17日

QC基準を満たした最初の提出物

2026年10月17日

最初の投稿 (実際)

2026年10月23日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月5日

QC基準を満たした最後の更新が送信されました

2026年11月4日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

キーワード

その他の研究ID番号

  • EarlyNutritionCardiac2025

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。